http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 23 Feb 2026 08:31:34 +0000 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Milestone+Scientific+launches+advisor+program+for+device+adoption/26039910.html <p>Milestone Scientific Inc. (NYSE: MLSS) announced the launch of its CompuFlo Advisor Program on February 1, targeting high-volume interventional pain and anesthesia practices in select Medicare Administrative Contractor jurisdictions.</p><p>The program focuses on Novitas, First Coast, Noridian, and Palmetto MAC jurisdictions as part of an initial phase before potential expansion to additional regions. The company aims to generate 1,000 to 2,000 case submissions during the first six months through engagement with key opinion leaders.</p><p>Milestone Scientific develops computerized drug delivery instruments that provide pressure-guided precision for medical and dental applications. The program targets practices using the company's technology to build clinical data http://www.streetinsider.com/Corporate+News/Milestone+Scientific+launches+advisor+program+for+device+adoption/26039910.html Mon, 23 Feb 2026 08:31:34 +0000 MLSS http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Launches+CompuFlo%C2%AE+Advisor+Program+to+Accelerate+Commercial+Adoption+and+Drive+Utilization+Growth+in+Select+MAC+Jurisdictions%3B+Plans+National+Expansion/26039882.html <p>ROSELAND, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- <strong>Milestone Scientific Inc. (NYSE: MLSS)</strong>, a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced the launch of the CompuFlo® Advisor Program. This strategic initiative is designed to drive mainstream commercial adoption, increase recurring disposable revenue, and generate the clinical data necessary to optimize long-term Medicare reimbursement rates.</p> <p>The program, which commenced on February 1, 2026, targets high-volume interventional pain and anesthesia practices within key Medicare Administrative Contractor (MAC) jurisdictions, including Novitas, First Coast, Noridian, and Palmetto. These jurisdictions represent a strategic first phase http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Launches+CompuFlo%C2%AE+Advisor+Program+to+Accelerate+Commercial+Adoption+and+Drive+Utilization+Growth+in+Select+MAC+Jurisdictions%3B+Plans+National+Expansion/26039882.html Mon, 23 Feb 2026 08:30:00 +0000 A.30142833 MLSS O.00003102 O.04998622 http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Launches+CompuFlo%C2%AE+Advisor+Program+to+Accelerate+Commercial+Adoption+and+Drive+Utilization+Growth+in+Select+MAC+Jurisdictions%3B+Plans+National+Expansion/26039882.html <p>ROSELAND, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- <strong>Milestone Scientific Inc. (NYSE: MLSS)</strong>, a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced the launch of the CompuFlo® Advisor Program. This strategic initiative is designed to drive mainstream commercial adoption, increase recurring disposable revenue, and generate the clinical data necessary to optimize long-term Medicare reimbursement rates.</p> <p>The program, which commenced on February 1, 2026, targets high-volume interventional pain and anesthesia practices within key Medicare Administrative Contractor (MAC) jurisdictions, including Novitas, First Coast, Noridian, and Palmetto. These jurisdictions represent a strategic first phase http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Launches+CompuFlo%C2%AE+Advisor+Program+to+Accelerate+Commercial+Adoption+and+Drive+Utilization+Growth+in+Select+MAC+Jurisdictions%3B+Plans+National+Expansion/26039882.html Mon, 23 Feb 2026 08:30:00 +0000 A.30142833 MLSS O.00003102 O.04998622 http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Launches+CompuFlo%C2%AE+Advisor+Program+to+Accelerate+Commercial+Adoption+and+Drive+Utilization+Growth+in+Select+MAC+Jurisdictions%3B+Plans+National+Expansion/26039882.html <p>ROSELAND, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- <strong>Milestone Scientific Inc. (NYSE: MLSS)</strong>, a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced the launch of the CompuFlo® Advisor Program. This strategic initiative is designed to drive mainstream commercial adoption, increase recurring disposable revenue, and generate the clinical data necessary to optimize long-term Medicare reimbursement rates.</p> <p>The program, which commenced on February 1, 2026, targets high-volume interventional pain and anesthesia practices within key Medicare Administrative Contractor (MAC) jurisdictions, including Novitas, First Coast, Noridian, and Palmetto. These jurisdictions represent a strategic first phase http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Launches+CompuFlo%C2%AE+Advisor+Program+to+Accelerate+Commercial+Adoption+and+Drive+Utilization+Growth+in+Select+MAC+Jurisdictions%3B+Plans+National+Expansion/26039882.html Mon, 23 Feb 2026 08:30:00 +0000 A.30142833 MLSS O.00003102 O.04998622 http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Launches+CompuFlo%C2%AE+Advisor+Program+to+Accelerate+Commercial+Adoption+and+Drive+Utilization+Growth+in+Select+MAC+Jurisdictions%3B+Plans+National+Expansion/26039882.html <p>ROSELAND, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- <strong>Milestone Scientific Inc. (NYSE: MLSS)</strong>, a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced the launch of the CompuFlo® Advisor Program. This strategic initiative is designed to drive mainstream commercial adoption, increase recurring disposable revenue, and generate the clinical data necessary to optimize long-term Medicare reimbursement rates.</p> <p>The program, which commenced on February 1, 2026, targets high-volume interventional pain and anesthesia practices within key Medicare Administrative Contractor (MAC) jurisdictions, including Novitas, First Coast, Noridian, and Palmetto. These jurisdictions represent a strategic first phase http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Launches+CompuFlo%C2%AE+Advisor+Program+to+Accelerate+Commercial+Adoption+and+Drive+Utilization+Growth+in+Select+MAC+Jurisdictions%3B+Plans+National+Expansion/26039882.html Mon, 23 Feb 2026 08:30:00 +0000 A.30142833 MLSS O.00003102 O.04998622 http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Launches+CompuFlo%C2%AE+Advisor+Program+to+Accelerate+Commercial+Adoption+and+Drive+Utilization+Growth+in+Select+MAC+Jurisdictions%3B+Plans+National+Expansion/26039882.html <p>ROSELAND, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- <strong>Milestone Scientific Inc. (NYSE: MLSS)</strong>, a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced the launch of the CompuFlo® Advisor Program. This strategic initiative is designed to drive mainstream commercial adoption, increase recurring disposable revenue, and generate the clinical data necessary to optimize long-term Medicare reimbursement rates.</p> <p>The program, which commenced on February 1, 2026, targets high-volume interventional pain and anesthesia practices within key Medicare Administrative Contractor (MAC) jurisdictions, including Novitas, First Coast, Noridian, and Palmetto. These jurisdictions represent a strategic first phase http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Launches+CompuFlo%C2%AE+Advisor+Program+to+Accelerate+Commercial+Adoption+and+Drive+Utilization+Growth+in+Select+MAC+Jurisdictions%3B+Plans+National+Expansion/26039882.html Mon, 23 Feb 2026 08:30:00 +0000 A.30142833 MLSS O.00003102 O.04998622 http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Launches+CompuFlo%C2%AE+Advisor+Program+to+Accelerate+Commercial+Adoption+and+Drive+Utilization+Growth+in+Select+MAC+Jurisdictions%3B+Plans+National+Expansion/26039882.html <p>ROSELAND, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- <strong>Milestone Scientific Inc. (NYSE: MLSS)</strong>, a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced the launch of the CompuFlo® Advisor Program. This strategic initiative is designed to drive mainstream commercial adoption, increase recurring disposable revenue, and generate the clinical data necessary to optimize long-term Medicare reimbursement rates.</p> <p>The program, which commenced on February 1, 2026, targets high-volume interventional pain and anesthesia practices within key Medicare Administrative Contractor (MAC) jurisdictions, including Novitas, First Coast, Noridian, and Palmetto. These jurisdictions represent a strategic first phase http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Launches+CompuFlo%C2%AE+Advisor+Program+to+Accelerate+Commercial+Adoption+and+Drive+Utilization+Growth+in+Select+MAC+Jurisdictions%3B+Plans+National+Expansion/26039882.html Mon, 23 Feb 2026 08:30:00 +0000 A.30142833 MLSS O.00003102 O.04998622 http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Launches+CompuFlo%C2%AE+Advisor+Program+to+Accelerate+Commercial+Adoption+and+Drive+Utilization+Growth+in+Select+MAC+Jurisdictions%3B+Plans+National+Expansion/26039882.html <p>ROSELAND, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- <strong>Milestone Scientific Inc. (NYSE: MLSS)</strong>, a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced the launch of the CompuFlo® Advisor Program. This strategic initiative is designed to drive mainstream commercial adoption, increase recurring disposable revenue, and generate the clinical data necessary to optimize long-term Medicare reimbursement rates.</p> <p>The program, which commenced on February 1, 2026, targets high-volume interventional pain and anesthesia practices within key Medicare Administrative Contractor (MAC) jurisdictions, including Novitas, First Coast, Noridian, and Palmetto. These jurisdictions represent a strategic first phase http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Launches+CompuFlo%C2%AE+Advisor+Program+to+Accelerate+Commercial+Adoption+and+Drive+Utilization+Growth+in+Select+MAC+Jurisdictions%3B+Plans+National+Expansion/26039882.html Mon, 23 Feb 2026 08:30:00 +0000 A.30142833 MLSS O.00003102 O.04998622 http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Launches+CompuFlo%C2%AE+Advisor+Program+to+Accelerate+Commercial+Adoption+and+Drive+Utilization+Growth+in+Select+MAC+Jurisdictions%3B+Plans+National+Expansion/26039882.html <p>ROSELAND, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- <strong>Milestone Scientific Inc. (NYSE: MLSS)</strong>, a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced the launch of the CompuFlo® Advisor Program. This strategic initiative is designed to drive mainstream commercial adoption, increase recurring disposable revenue, and generate the clinical data necessary to optimize long-term Medicare reimbursement rates.</p> <p>The program, which commenced on February 1, 2026, targets high-volume interventional pain and anesthesia practices within key Medicare Administrative Contractor (MAC) jurisdictions, including Novitas, First Coast, Noridian, and Palmetto. These jurisdictions represent a strategic first phase http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Launches+CompuFlo%C2%AE+Advisor+Program+to+Accelerate+Commercial+Adoption+and+Drive+Utilization+Growth+in+Select+MAC+Jurisdictions%3B+Plans+National+Expansion/26039882.html Mon, 23 Feb 2026 08:30:00 +0000 A.30142833 MLSS O.00003102 O.04998622 http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++MILESTONE+SCIENTIFIC++++++For%3A+Jan+15/25944432.html si-local-file:///var/storage/secattach/20260204/25944432.html http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++MILESTONE+SCIENTIFIC++++++For%3A+Jan+15/25944432.html Wed, 04 Feb 2026 09:26:00 +0000 MLSS O.04998622 http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++MILESTONE+SCIENTIFIC++++++For%3A+Jan+15/25944432.html si-local-file:///var/storage/secattach/20260204/25944432.html http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++MILESTONE+SCIENTIFIC++++++For%3A+Jan+15/25944432.html Wed, 04 Feb 2026 09:26:00 +0000 MLSS O.04998622